Does Depo-Provera Cause Bone Density Loss?
Yes, Depo-Provera (medroxyprogesterone acetate injectable suspension) can cause bone mineral density (BMD) loss. The FDA label warns of significant BMD reductions in studies of adolescents and adults, linked to its progestin-only mechanism suppressing estrogen, which protects bone health.[1] Losses average 1-2% per year at the spine and hip with long-term use (over 2 years), potentially partially reversing after discontinuation but not always fully.[2]
How Common Is Bone Loss with Depo-Provera?
In clinical trials, 94% of adolescents on Depo-Provera for 2 years lost lumbar spine BMD (mean -0.54% to -5.2% depending on dose/duration), compared to gains in controls.[1] Adult data shows similar declines: up to 5-7% over 5 years at the femoral neck.[3] Risk rises with longer use, low body weight, smoking, or conditions like amenorrhea. Not all users experience it—some studies report minimal change short-term—but monitoring is advised.[2]
Why Does It Happen and Who Is Most at Risk?
Depo-Provera suppresses ovulation and estrogen production, mimicking low-estrogen states like menopause that accelerate bone resorption. High-risk groups include women under 18 (whose bones are still developing), long-term users (≥2 years), those with eating disorders, heavy smokers, or on corticosteroids.[1][4] The FDA recommends BMD testing in these cases and switching to alternatives if loss occurs.[1]
What Happens If You Stop Depo-Provera?
BMD often recovers partially after stopping: spine density rebounds ~5-6% within 2 years in adolescents, though hip recovery is slower and incomplete in some adults.[2][3] Full reversal isn't guaranteed, especially after 5+ years, raising long-term fracture risk concerns. No direct fracture data exists from trials, but experts urge caution for perimenopausal users.[4]
How Can You Prevent or Manage Bone Loss?
- Use the lowest effective dose and shortest duration.
- Ensure 1,200-1,500 mg daily calcium + 400-800 IU vitamin D.
- Weight-bearing exercise (e.g., walking, resistance training).
- BMD screening via DXA scan before long-term use or if risks present.
- Discontinue if significant loss detected; consider estrogen add-back in select cases (off-label).[1][2]
Alternatives to Depo-Provera with Lower Bone Risk
Combined hormonal options (e.g., pills with estrogen/progestin) or progestin-only implants like Nexplanon show neutral or positive BMD effects.[4] IUDs (Mirena, Kyleena) have minimal impact. Copper IUDs avoid hormones entirely. Consult providers for personalized switches—e.g., if contraception is the goal, long-acting reversible methods preserve bone better long-term.[3]
FDA Warnings and Guidelines
The black-box warning flags prolonged use (>2 years) unless other methods unavailable, due to irreversible BMD loss risk. ACOG advises against routine use in adolescents; WHO limits to 2 years in breastfeeding or high-risk scenarios.[1][4] No patent data specific to bone effects (DrugPatentWatch.com tracks formulation patents expiring 2025-2030, but generics available).[5]
[1]: FDA Label for Depo-Provera
[2]: NEJM Study on BMD Loss (2006)
[3]: WHO Medical Eligibility Criteria
[4]: ACOG Committee Opinion #815
[5]: DrugPatentWatch.com - Depo-Provera